TOP HEADLINES

FEATURED STORY

  • LabCorp seals its $6B deal for Covance

    One of the world's largest CROs is no longer an independent entity as Covance has folded into testing giant LabCorp, closing a $6 billion deal and altering the industry landscape.

     

Parexel stretches out its site network to speed up enrollment

CRO giant Parexel International has expanded its Rolodex of clinical trial sites to more than 180 around the world, a network the company says allows it to more quickly find patients for studies.

Theorem partners up for patient testing

Theorem Clinical Research has signed a deal with Biomedical Systems to expands its testing services, enlisting a partner with expertise in diagnostics.

WuXi borrows $165M to bankroll more M&A

Acquisitive Chinese CRO WuXi PharmaTech is borrowing up to $165 million to keep up its string of deals, eyeing investments in R&D and manufacturing.

Quintiles shedding 270 jobs in a cost-cutting move

Global CRO Quintiles is planning to lay off about 270 workers, 1% of its payroll, in an effort to reduce "excess capacity," the company said.

AMRI posts a net quarterly loss in the midst of a realignment

Marred by bad weather and an ongoing transition, contract drug developer AMRI swung to a loss in the fourth quarter, but steady gains in revenue have the company optimistic about the coming year.

MORE NEWS

From Our Sister Sites

FierceAnimalHealth

Petaluma, CA-based Oculus Innovative Sciences announced Thursday that it has launched an animal health unit and 6 new products for the treatment of wounds, skin and eyes.

FierceMedicalDevices

St. Jude Medical agreed to pay as much as $14.25 million to settle about 950 claims related to its Riata defibrillator leads. The wires used to shock a heart that is beating abnormally degraded in as few as four years and were pulled from the market in 2010.